QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 5 August 2003
doi: 10.1242/jcs.00694

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.00694v1 116/18/3803    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levchenko, T. Articles by Holmgren, L. Search for Related Content PubMed PubMed Citation Articles by Levchenko, T. Articles by Holmgren, L. Social Bookmarking                         What's this?

Loss of responsiveness to chemotactic factors by deletion of the C-terminal protein interaction site of angiomotin

Department of Oncology-Pathology, Cancer Center Karolinska Institutet, S-17176 Stockholm, Sweden

^* Author for correspondence (e-mail: lars.holmgren{at}cck.ki.se)

Accepted 29 May 2003

We have recently identified a novel protein, named angiomotin, by its ability to bind the angiogenesis inhibitor angiostatin in the yeast two-hybrid system. Angiomotin belongs to a family with two other members, AmotL-1 and -2 characterized by coiled-coil and C-terminal PDZ binding domains. Here we show that the putative PDZ binding motif of angiomotin serves as a protein recognition site and that deletion of three amino acids in this site results in inhibition of chemotaxis. Furthermore, endothelial cells expressing mutant angiomotin failed to migrate and form tubes in an in vitro tube formation assay. To study the effect of angiomotin on embryonic angiogenesis, we generated transgenic mice expressing wild-type angiomotin and the C-terminal deletion mutant driven by the endothelial cell-specific receptor tyrosine kinase (TIE) promoter. Expression of mutant angiomotin in endothelial cells inhibited migration into the neuroectoderm and intersomitic regions resulting in death at embryonic day 9.5. In contrast, mice expressing wild-type angiomotin developed normally and were fertile. These results suggest that the putative PDZ binding motif of angiomotin plays a critical role in regulating the responsiveness of endothelial cells to chemotactic cues.

Key words: Endothelium, Neovascularization, Migration, Plasminogen, Receptor

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. Roudier, N. Chapados, S. Decary, C. Gineste, C. Le Bel, J.-M. Lavoie, R. Bergeron, and O. Birot Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats? J. Physiol., August 15, 2009; 587(16): 4105 - 4119. [Abstract] [Full Text] [PDF]

				J. W. Ross, M. D. Ashworth, D. R. Stein, O. P. Couture, C. K. Tuggle, and R. D. Geisert Identification of differential gene expression during porcine conceptus rapid trophoblastic elongation and attachment to uterine luminal epithelium Physiol Genomics, February 2, 2009; 36(3): 140 - 148. [Abstract] [Full Text] [PDF]

				M. Ernkvist, N. L. Persson, S. Audebert, P. Lecine, I. Sinha, M. Liu, M. Schlueter, A. Horowitz, K. Aase, T. Weide, et al. The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells Blood, January 1, 2009; 113(1): 244 - 253. [Abstract] [Full Text] [PDF]

				T. Levchenko, N. Veitonmaki, A. Lundkvist, H. Gerhardt, Y. Ming, K. Berggren, A. Kvanta, R. Carlsson, and L. Holmgren Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo FASEB J, March 1, 2008; 22(3): 880 - 889. [Abstract] [Full Text] [PDF]

				K. Aase, M. Ernkvist, L. Ebarasi, L. Jakobsson, A. Majumdar, C. Yi, O. Birot, Y. Ming, A. Kvanta, D. Edholm, et al. Angiomotin regulates endothelial cell migration during embryonic angiogenesis Genes & Dev., August 15, 2007; 21(16): 2055 - 2068. [Abstract] [Full Text] [PDF]

				Y. Sugihara-Mizuno, M. Adachi, Y. Kobayashi, Y. Hamazaki, M. Nishimura, T. Imai, M. Furuse, and S. Tsukita Molecular characterization of angiomotin/JEAP family proteins: interaction with MUPP1/Patj and their endogenous properties Genes Cells, April 1, 2007; 12(4): 473 - 486. [Abstract] [Full Text] [PDF]

				H. Huang, F.-I Lu, S. Jia, S. Meng, Y. Cao, Y. Wang, W. Ma, K. Yin, Z. Wen, J. Peng, et al. Amotl2 is essential for cell movements in zebrafish embryo and regulates c-Src translocation Development, March 1, 2007; 134(5): 979 - 988. [Abstract] [Full Text] [PDF]

				L. Holmgren, E. Ambrosino, O. Birot, C. Tullus, N. Veitonmaki, T. Levchenko, L.-M. Carlson, P. Musiani, M. Iezzi, C. Curcio, et al. A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth PNAS, June 13, 2006; 103(24): 9208 - 9213. [Abstract] [Full Text] [PDF]

				A. Bratt, O. Birot, I. Sinha, N. Veitonmaki, K. Aase, M. Ernkvist, and L. Holmgren Angiomotin Regulates Endothelial Cell-Cell Junctions and Cell Motility J. Biol. Chem., October 14, 2005; 280(41): 34859 - 34869. [Abstract] [Full Text] [PDF]